The arrival of Retatrutide ZPHC, at a strength of 120mg, is generating considerable excitement within the weight loss community. This novel dual GIP and GLP-1 target medication suggests to provide significant improvements in weight reduction compared to current therapies. Preliminary clinical studies have indicated significant reductions in body fa